Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Epstein-Barr virus Zta upregulates matrix metalloproteinases 3 and 9 that synergistically promote cell invasion in vitro.

Lan YY, Yeh TH, Lin WH, Wu SY, Lai HC, Chang FH, Takada K, Chang Y.

PLoS One. 2013;8(2):e56121. doi: 10.1371/journal.pone.0056121. Epub 2013 Feb 7.

3.

Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9.

Lan YY, Hsiao JR, Chang KC, Chang JS, Chen CW, Lai HC, Wu SY, Yeh TH, Chang FH, Lin WH, Su IJ, Chang Y.

J Virol. 2012 Jun;86(12):6656-67. doi: 10.1128/JVI.00174-12. Epub 2012 Apr 18.

4.

Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells.

Hsu M, Wu SY, Chang SS, Su IJ, Tsai CH, Lai SJ, Shiau AL, Takada K, Chang Y.

J Virol. 2008 Apr;82(7):3679-88. doi: 10.1128/JVI.02301-07. Epub 2008 Jan 30.

5.

CCAAT/enhancer binding protein alpha interacts with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G(1) cell cycle arrest during the Epstein-Barr virus lytic cycle.

Wu FY, Chen H, Wang SE, ApRhys CM, Liao G, Fujimuro M, Farrell CJ, Huang J, Hayward SD, Hayward GS.

J Virol. 2003 Jan;77(2):1481-500.

6.

Epstein-Barr virus Zta-induced immunomodulators from nasopharyngeal carcinoma cells upregulate interleukin-10 production from monocytes.

Lee CH, Yeh TH, Lai HC, Wu SY, Su IJ, Takada K, Chang Y.

J Virol. 2011 Jul;85(14):7333-42. doi: 10.1128/JVI.00182-11. Epub 2011 May 4.

8.

Upregulation of tyrosine kinase TKT by the Epstein-Barr virus transactivator Zta.

Lu J, Chen SY, Chua HH, Liu YS, Huang YT, Chang Y, Chen JY, Sheen TS, Tsai CH.

J Virol. 2000 Aug;74(16):7391-9.

9.

Regulation of matrix metalloproteinase-1 by Epstein-Barr virus proteins.

Lu J, Chua HH, Chen SY, Chen JY, Tsai CH.

Cancer Res. 2003 Jan 1;63(1):256-62.

11.

Contribution of C/EBP proteins to Epstein-Barr virus lytic gene expression and replication in epithelial cells.

Huang J, Liao G, Chen H, Wu FY, Hutt-Fletcher L, Hayward GS, Hayward SD.

J Virol. 2006 Feb;80(3):1098-109.

12.

Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.

Li D, Qian L, Chen C, Shi M, Yu M, Hu M, Song L, Shen B, Guo N.

J Immunol. 2009 Feb 15;182(4):1799-809. doi: 10.4049/jimmunol.0802686.

13.

Induction of the early growth response 1 gene by Epstein-Barr virus lytic transactivator Zta.

Chang Y, Lee HH, Chen YT, Lu J, Wu SY, Chen CW, Takada K, Tsai CH.

J Virol. 2006 Aug;80(15):7748-55.

14.

The Epstein-Barr virus lytic cycle activator Zta interacts with methylated ZRE in the promoter of host target gene egr1.

Heather J, Flower K, Isaac S, Sinclair AJ.

J Gen Virol. 2009 Jun;90(Pt 6):1450-4. doi: 10.1099/vir.0.007922-0. Epub 2009 Mar 4.

15.

Matrix metalloproteinase 9 is induced by the Epstein-Barr virus BZLF1 transactivator.

Yoshizaki T, Sato H, Murono S, Pagano JS, Furukawa M.

Clin Exp Metastasis. 1999 Jul;17(5):431-6.

PMID:
10651310
16.
17.

Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.

Lee DC, Chua DT, Wei WI, Sham JS, Lau AS.

Biomed Pharmacother. 2007 Oct;61(9):520-6. Epub 2007 Sep 14.

PMID:
17913445
18.
19.

DNA-binding-defective mutants of the Epstein-Barr virus lytic switch activator Zta transactivate with altered specificities.

Flemington EK, Lytle JP, Cayrol C, Borras AM, Speck SH.

Mol Cell Biol. 1994 May;14(5):3041-52.

20.

The Epstein-Barr virus lytic transactivator Zta interacts with the helicase-primase replication proteins.

Gao Z, Krithivas A, Finan JE, Semmes OJ, Zhou S, Wang Y, Hayward SD.

J Virol. 1998 Nov;72(11):8559-67.

Supplemental Content

Support Center